CGRP-Uric Acid Axis Proposed as Redox-Inflammatory Framework Linking Neurovascular and Metabolic Regulation in Migraine
Background
Migraine is a complex neurovascular disorder involving intricate interactions between neuronal, vascular, inflammatory, and metabolic processes. Calcitonin gene-related peptide (CGRP) is a well-established key mediator within the trigeminovascular system, playing a crucial role in migraine pathophysiology and serving as a target for recent preventive therapies. While uric acid (UA) is increasingly recognized for its influence on redox balance and inflammatory signaling, its mechanistic link to CGRP in migraine has often been discussed separately. This gap highlights the need for an integrated understanding of how these pathways converge to drive migraine attacks.
Study Design
This review systematically summarized current evidence regarding CGRP signaling, oxidative stress, and uric acid metabolism to bridge previously disconnected mechanistic discussions. The authors synthesized findings from various studies, including those on CGRP's role in neurovascular function and UA's context-dependent effects on redox and inflammation. Based on this comprehensive synthesis, they proposed a novel, hypothesis-generating CGRP-UA redox-inflammatory framework for migraine, aiming to integrate these distinct but potentially interacting pathways within the trigeminovascular system.
Results
The proposed framework posits that CGRP-associated oxidative stress significantly contributes to neuronal sensitization and neurogenic inflammation in migraine. This oxidative stress acts as a crucial link, connecting neuropeptide activity with downstream immune and metabolic responses. Uric acid demonstrates context-dependent effects: it functions as an extracellular antioxidant by scavenging radicals, breaking lipid peroxidation chains, and chelating metals. Conversely, intracellular accumulation of UA can contribute to oxidative stress and activate the NLRP3 inflammasome.
These intricate pathways appear to converge on shared mediators, including reactive oxygen species (ROS), nuclear factor kappa B (NF-κB), and the
NLRP3 inflammasome, suggesting critical interactions within the trigeminovascular system that could drive migraine pathology.
Key Findings
- Proposed a CGRP-UA redox-inflammatory framework for migraine pathophysiology.
- CGRP activity linked to oxidative stress, neuronal sensitization, and neurogenic inflammation.
- Uric acid exhibits context-dependent effects, acting as an antioxidant or pro-oxidant.
- Pathways converge on shared mediators like
ROS,NF-κB, andNLRP3 inflammasome. - Framework is hypothesis-generating, guiding future migraine research and therapeutic targets.
Why It Matters
This integrative framework offers a novel lens for understanding migraine pathophysiology, moving beyond isolated mechanisms to a more holistic view. For peptide users and clinicians, understanding the CGRP-UA axis could open new avenues for therapeutic targeting, potentially leading to combination therapies that address both neurovascular and metabolic aspects of migraine. While currently conceptual, this model provides a roadmap for future research, guiding investigations into novel biomarkers and therapeutic strategies. It suggests that interventions targeting oxidative stress or uric acid metabolism, perhaps in conjunction with CGRP pathway modulation, could offer enhanced efficacy for migraine prevention or acute treatment. This could lead to more personalized and effective protocols in the long term.
migraine
cgrp
uric-acid
oxidative-stress
inflammation
neurovascular